Annual Accounts Receivable
$107.60 K
-$47.10 K-30.45%
31 December 2023
Summary:
Cardiol Therapeutics annual accounts receivable is currently $107.60 thousand, with the most recent change of -$47.10 thousand (-30.45%) on 31 December 2023. During the last 3 years, it has risen by +$103.10 thousand (+2291.11%). CRDL annual accounts receivable is now -30.45% below its all-time high of $154.70 thousand, reached on 31 December 2022.CRDL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$42.20 K
-$26.20 K-38.30%
30 September 2024
Summary:
Cardiol Therapeutics quarterly accounts receivable is currently $42.20 thousand, with the most recent change of -$26.20 thousand (-38.30%) on 30 September 2024. Over the past year, it has dropped by -$88.70 thousand (-67.76%). CRDL quarterly accounts receivable is now -72.72% below its all-time high of $154.70 thousand, reached on 31 December 2022.CRDL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.4% | -67.8% |
| 3 y3 years | +2291.1% | -24.8% |
| 5 y5 years | - | - |
CRDL Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -30.4% | +2291.1% | -72.7% | at low |
| 5 y | 5 years | -30.4% | +2291.1% | -72.7% | +837.8% |
| alltime | all time | -30.4% | +2291.1% | -72.7% | +837.8% |
Cardiol Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $42.20 K(-38.3%) |
| June 2024 | - | $68.40 K(-40.0%) |
| Mar 2024 | - | $114.00 K(+5.9%) |
| Dec 2023 | $107.60 K(-30.4%) | $107.60 K(-17.8%) |
| Sept 2023 | - | $130.90 K(-7.9%) |
| June 2023 | - | $142.10 K(-2.9%) |
| Mar 2023 | - | $146.30 K(-5.4%) |
| Dec 2022 | $154.70 K | $154.70 K(+37.3%) |
| Sept 2022 | - | $112.70 K(+15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $97.30 K(+37.8%) |
| Mar 2022 | - | $70.60 K(+36.8%) |
| Dec 2021 | $51.60 K(+1046.7%) | - |
| Dec 2021 | - | $51.60 K(-8.0%) |
| Sept 2021 | - | $56.10 K(-38.8%) |
| June 2021 | - | $91.60 K(+158.8%) |
| Mar 2021 | - | $35.40 K(+686.7%) |
| Dec 2020 | $4500.00(-49.4%) | $4500.00(-49.4%) |
| Dec 2019 | $8900.00 | $8900.00 |
FAQ
- What is Cardiol Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual accounts receivable year-on-year change?
- What is Cardiol Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly accounts receivable year-on-year change?
What is Cardiol Therapeutics annual accounts receivable?
The current annual accounts receivable of CRDL is $107.60 K
What is the all time high annual accounts receivable for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual accounts receivable is $154.70 K
What is Cardiol Therapeutics annual accounts receivable year-on-year change?
Over the past year, CRDL annual accounts receivable has changed by -$47.10 K (-30.45%)
What is Cardiol Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of CRDL is $42.20 K
What is the all time high quarterly accounts receivable for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly accounts receivable is $154.70 K
What is Cardiol Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, CRDL quarterly accounts receivable has changed by -$88.70 K (-67.76%)